Nano-Based Drug Delivery and Drug Discovery

Dear Colleagues,

Nanotechnology involves the manipulation and utilization of materials, devices, and systems at the nanometer scale. This rapidly evolving field presents numerous opportunities and a wide array of applications across engineering, medicine, and life sciences. Drug delivery encompasses the various methods by which a drug or active agent is transported to target cells to address health issues or diseases. Nanotechnology shows promise as the preferred platform for drug delivery when addressing the challenges of conventional medications used in the treatment and management of various diseases and developing innovative treatment and diagnostic approaches. By using nanoparticles, drug bioavailability can be enhanced, targeted drug accumulation can be increased, and drug-related side effects can be minimized, ultimately resulting in improved therapeutic outcomes and enhanced patient adherence to treatment protocols.

Potential topics include, but are not limited to, the following:

• Drug targeting and release (nanoparticles functionalization and optimization, and stimuli-responsive targeting and releasing).
• Multiple drug administration (multifunctional nanoparticles, combination nanomedicines, personalized nanomedicine, theragnostic nanoparticles, and sequential drug release).
• Nanocarriers in drug delivery (design and optimization of nanocarriers, and the role of nanocarriers in drug delivery).
• Smart drug delivery system and its clinical potential.
• Applications of nano-based systems for drug delivery.

Dr. Xiangli Shao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanotechnology
• drug discovery
• drug delivery
• nanocarriers
• nanomaterials
• drug targeting
• drug release
• drug therapeutic